Latent herpesvirus infection augments experimental pulmonary fibrosis
about
Gammaherpesviruses and pulmonary fibrosis: evidence from humans, horses, and rodentsCellular mechanisms of tissue fibrosis. 7. New insights into the cellular mechanisms of pulmonary fibrosisViruses in Idiopathic Pulmonary Fibrosis. Etiology and ExacerbationRespiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment.Following the path of CCL2 from prostaglandins to periostin in lung fibrosisγ-Herpes virus-68, but not Pseudomonas aeruginosa or influenza A (H1N1), exacerbates established murine lung fibrosisInhibition of NF-kappaB signaling reduces virus load and gammaherpesvirus-induced pulmonary fibrosisDetection of herpes simplex virus type-1 in patients with fibrotic lung diseasesInnate immune activation by inhaled lipopolysaccharide, independent of oxidative stress, exacerbates silica-induced pulmonary fibrosis in mice.Latent infection by γherpesvirus stimulates profibrotic mediator release from multiple cell types.Herpes virus infection is associated with vascular remodeling and pulmonary hypertension in idiopathic pulmonary fibrosisDiffuse alveolar damage: a common phenomenon in progressive interstitial lung disordersExperimental induction of pulmonary fibrosis in horses with the gammaherpesvirus equine herpesvirus 5.Ganciclovir antiviral therapy in advanced idiopathic pulmonary fibrosis: an open pilot studyProstaglandin E2 and the pathogenesis of pulmonary fibrosis.Severe gammaherpesvirus-induced pneumonitis and fibrosis in syngeneic bone marrow transplant mice is related to effects of transforming growth factor-β.Clinical review: idiopathic pulmonary fibrosis acute exacerbations--unravelling Ariadne's thread.CD8+ T Cell Response to Gammaherpesvirus Infection Mediates Inflammation and Fibrosis in Interferon Gamma Receptor-Deficient MiceRight place, right time: the evolving role of herpesvirus infection as a "second hit" in idiopathic pulmonary fibrosisStress responses affecting homeostasis of the alveolar capillary unit.Pulmonary fibrosis induced by γ-herpesvirus in aged mice is associated with increased fibroblast responsiveness to transforming growth factor-β.Current and novel drug therapies for idiopathic pulmonary fibrosis.Equine multinodular pulmonary fibrosis in association with asinine herpesvirus type 5 and equine herpesvirus type 5: a case report.Establishment of a mouse model for pulmonary inflammation and fibrosis by intratracheal instillation of polyhexamethyleneguanidine phosphate.Animal models of fibrotic lung disease.Lung bone marrow-derived hematopoietic progenitor cells enhance pulmonary fibrosis.Immunohistochemical detection of virus through its nuclear cytopathic effect in idiopathic interstitial pneumonia other than acute exacerbation.Nanoparticle exposure reactivates latent herpesvirus and restores a signature of acute infection.Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.Viral infection and aging as cofactors for the development of pulmonary fibrosis.Update in diffuse parenchymal lung disease 2010.Self-eating: friend or foe? The emerging role of autophagy in idiopathic pulmonary fibrosis.TLR9-induced interferon β is associated with protection from gammaherpesvirus-induced exacerbation of lung fibrosis.Targeting defective Toll-like receptor-3 function and idiopathic pulmonary fibrosis.Emerging roles of innate immune signaling and toll-like receptors in fibrosis and systemic sclerosis.Influences of innate immunity, autophagy, and fibroblast activation in the pathogenesis of lung fibrosis.Bone marrow transplantation alters lung antigen-presenting cells to promote TH17 response and the development of pneumonitis and fibrosis following gammaherpesvirus infection.Loss of CCR2 signaling alters leukocyte recruitment and exacerbates γ-herpesvirus-induced pneumonitis and fibrosis following bone marrow transplantation.The Epstein-Barr virus latent membrane protein 1 and transforming growth factor--β1 synergistically induce epithelial--mesenchymal transition in lung epithelial cells.The anti-fibrotic effect of inhibition of TGFβ-ALK5 signalling in experimental pulmonary fibrosis in mice is attenuated in the presence of concurrent γ-herpesvirus infection.
P2860
Q26829291-42B273E8-F33E-4398-816C-4DB409617EF1Q27003892-4B2D5D00-DFD0-4A19-BF05-53FF85570E6DQ28081676-ED1CFBA6-C7F6-4299-8B23-A235C384932AQ30240274-A18A0384-E9CF-45D6-A0BB-9EB8CB72417EQ33799756-FB3A88B6-AA80-405F-8706-BED158D891F7Q34001662-C49A3DDF-0D9D-46C9-BD9C-D2CEF5A1419BQ34033532-B1C1A8A5-1FC8-4071-8BC9-5F102DF645C8Q34113496-B9E0ED6B-27CD-4D30-A771-CDAAB642863BQ34345194-9C3F621D-ADDF-4981-97F7-57254EB06CDAQ34598816-17D438E6-8D16-4E6E-A237-5E83F5A78F53Q34611385-D882D3C7-BAF4-4BEE-A1F0-7A260F2C96BFQ34998351-871A7F28-A9D6-4E9D-9775-4CCD8AB79BEAQ35023396-DE80051E-5B6B-4466-98A8-9520C4EB77EAQ35028793-1D1F28D5-6E0E-422C-84FA-049D14BAF68FQ35219865-19FF225E-A0BC-4F0D-BD6E-EFCA691C303AQ35474602-E4DFE51C-B48A-44E7-A706-3DB6A854C0B3Q35561400-745617B8-749E-4E6A-981C-37989CC6368BQ35758535-20612CCB-AB6E-4F18-931C-0AF451EFE3E9Q35850237-3BD8E060-80AC-423E-B53E-B0C394F8F30CQ35983853-C90F3F76-8E9E-4ECF-BA5E-EA1CF5015FB4Q36080171-D5996720-6764-45E6-BDF9-B6B2B1773188Q36294959-7DB66254-F114-4DDE-9EFD-11B35919F1A0Q36439078-5D7C7830-00A2-4BBA-B1E9-944BA94AA79EQ36898503-672BA121-1816-462A-876F-D984ADA76583Q37297925-22AF1923-0E02-44F8-9E4F-F4EC3EA6E91FQ37304394-E84FA9A0-32C2-489B-9148-1C2AE504DE9AQ37371297-3B668D70-D869-49A3-8CC6-8866049E18A2Q37576530-84CE5891-792C-4866-A6A2-46070DFD3946Q37651549-60DD81BA-42B2-4D8C-8E6D-580421F47670Q37815487-7C63162C-06B8-4894-802B-4F3B6B798ABFQ37877430-64CBF721-8A10-468E-B9E1-F4BD23AEE083Q38108325-C8CC6ED2-80B0-43F9-976E-166A38BD48DEQ38267788-2FC2808E-B4D4-4670-B16B-670E83696AE8Q38296340-AE33EAD2-956B-4C3B-941B-43BB3D077097Q38325712-B1F8A3C1-F2F0-4E51-ADFA-073A2AE7DC58Q38913044-CB096C6B-2A8A-4F80-81FE-3D85D8C47B5BQ39052615-01668C4F-607A-4C17-A345-061577C10BA1Q39569560-EEED6E52-147A-4965-8F12-367795151453Q39669856-ACFED640-A96E-4CA5-9105-FDD0F68B6FB5Q40772569-C57D7AAF-0F14-4491-A5C2-E5B73C26F9C5
P2860
Latent herpesvirus infection augments experimental pulmonary fibrosis
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Latent herpesvirus infection augments experimental pulmonary fibrosis
@en
Latent herpesvirus infection augments experimental pulmonary fibrosis.
@nl
type
label
Latent herpesvirus infection augments experimental pulmonary fibrosis
@en
Latent herpesvirus infection augments experimental pulmonary fibrosis.
@nl
prefLabel
Latent herpesvirus infection augments experimental pulmonary fibrosis
@en
Latent herpesvirus infection augments experimental pulmonary fibrosis.
@nl
P2093
P2860
P1476
Latent herpesvirus infection augments experimental pulmonary fibrosis
@en
P2093
Bethany B Moore
Carol A Wilke
Galen B Toews
Kevin M Vannella
Linda F van Dyk
Tracy R Luckhardt
P2860
P304
P356
10.1164/RCCM.200905-0798OC
P407
P577
2009-12-10T00:00:00Z